Extension of the randomized, double-blind, placebo-controlled single ascending dose study to assess the safety and tolerability of AP30663 in healthy subjects.

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2020
This article has no abstract
Epistemonikos ID: b936492fb77c2d49c1b10bca6e5b50840a5f1076
First added on: Apr 11, 2025